CIENCIASMEDICASNEWS

sábado, 17 de octubre de 2026

Clues to what causes multiple sclerosis

Clues to what causes multiple sclerosis Pointing toward better treatments Multiple sclerosis is a disease where the body’s immune system attacks the central nervous system. There is no cure, although there are treatments that can reduce the number and severity of relapses. Scientists are studying the disease’s underlying biology to find new clues about its causes and better ways to treat it. https://www.nih.gov/news-events/nih-research-matters/clues-what-causes-multiple-sclerosis

Breast Cancer

https://www.cancer.gov/types/breast Breast Cancer Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread. Explore the links on this page to learn more about breast cancer prevention, screening, treatment, statistics, research, clinical trials, and more.

From Resection to Dose Individualized Antigen-Directed Therapeutics in Immuno-Oncology CME Phoenix Convention Center Saturday, November 7, 2026 | 12:30 pm - 1:30 pm MT

From Resection to Dose Individualized Antigen-Directed Therapeutics in Immuno-Oncology CME Phoenix Convention Center https://na.eventscloud.com/website/100106/ Saturday, November 7, 2026 | 12:30 pm - 1:30 pm MT Messenger RNA (mRNA)-based therapeutics have moved from concept into clinical evaluation across immuno-oncology. This symposium discusses how mRNA-encoded, antigen-directed approaches generate anti-tumor immunity, and how they sit alongside checkpoint inhibition, cell therapy and other novel modalities. Faculty will cover the mechanistic basis of mRNA therapies — antigen selection and prediction, delivery, and the resulting T-cell priming and expansion — and how this differs from other immunotherapeutic approaches. The program will review current clinical evidence across tumor types and disease settings, including earlier-stage and minimal residual disease contexts, matching the strength of each conclusion to the design that produced it. Sessions will also address biomarker and patient-selection considerations, including tumor mutational burden, neoantigen burden and circulating tumor DNA (ctDNA)-based measures, and the multidisciplinary requirements of delivering individualized therapies in practice. The From Resection to Dose: Individualized Antigen-Directed Therapeutics in Immuno-Oncology, content and views expressed therein are those of Medscape Education and not of SITC.

Most Read Cancer Science & Oncogenesis (+...)

https://read.qxmd.com/collection/1133?ecd=wnl_readmost_261016

Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Hope Rugo, MD; Peter A. Fasching, MD (++)

Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Hope Rugo, MD; Peter A. Fasching, MD https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?page=1&src=mkmcmr_driv_32025_mscpedu_451770.18_ace_launch-ret&uac=148436CN Latest Breakthroughs in Breast Care Management: Highlights From Chicago 2026 Authors: Erica L. Mayer, MD, MPH; Michael Untch, MD, PhD; Sherene M. Loi, MD, PhD https://www.medscape.org/viewarticle/latest-breakthroughs-breast-care-management-highlights-2026a1000kok?page=1&src=mkmcmr_driv_32025_mscpedu_451770.18_ace_launch-ret&uac=148436CN

When the GI Workup Doesn’t Explain the Symptoms Alli Spotts-De Lazzer, MA

https://www.medscape.com/viewarticle/when-gi-workup-doesnt-explain-symptoms-2026a10011tj?ecd=WNL_trdalrt_pos1_ous_261016_etid8801359&uac=148436CN&impID=8801359 Your patient reports ongoing constipation, feeling full after a few bites, bloating, and nausea after meals. You order a gastric emptying study, and it shows delayed emptying. What’s on your differential? A motility disorder? Medication effect? Another gastrointestinal condition?